Page 1
__________________________________________________________________________________________
Page 1 of 12
Safety Data Sheet
All rights reserved. Copying and/or downloading of this information for the purpose of properly utilizing Sakrete of North
America products is allowed provided that: (1) the information is copied in full with no changes unless prior written
agreement is obtained from Sakrete of North America, and (2) neither the copy nor the original is resold or otherwise
distributed with the intention of earning a profit thereon.
Version Number:
3.01
Issue Date:
0
6/19/14; Rev 03-19-2015
Supercedes Date:
05/09/14
SECTION 1: Identification
1.1. Product identifier
Sakrete Polyurethane Non Sag Sealant
1.2. Recommended use and restrictions on use
Recommended use
Sealant
1.3. Supplier’s details
Supplier Info:
Sakrete of North America
ADDRESS:
Telephone:
8201 Arrowridge Blvd., Charlotte, NC 28273
866-725-7383
1.4.
Emergency telephone number
Chemtrec: 800-424-9300 International +01-703-527-3887
SECTION 2: Hazard identification
2.1. Hazard classification
Serious Eye Damage/Irritation: Category 2A.
Skin Corrosion/Irritation: Category 2.
Carcinogenicity: Category 2.
Specific Target Organ Toxicity (single exposure): Category 1.
Specific Target Organ Toxicity (repeated exposure): Category 1.
2.2. Label elements
Signal word
Danger
Symbols
Exclamation mark | Health Hazard |
Pictograms
Page 2
__________________________________________________________________________________________
Page 2 of 12
Hazard Statements
Causes serious eye irritation.
Causes skin irritation.
Suspected of causing cancer.
Causes damage to organs:
sensory organs |
Causes damage to organs through prolonged or repeated exposure:
nervous system |
May cause damage to organs through prolonged or repeated exposure:
sensory organs |
Precautionary Statements
General:
Keep out of reach of children.
Prevention:
Obtain special instructions before use.
Do not handle until all safety precautions have been read and understood.
Do not breathe dust/fume/gas/mist/vapors/spray.
Wear protective gloves and eye/face protection.
Do not eat, drink or smoke when using this product.
Wash thoroughly after handling.
Response:
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do.
Continue rinsing.
If eye irritation persists: Get medical advice/attention.
IF ON SKIN: Wash with plenty of soap and water.
If skin irritation occurs: Get medical advice/attention.
Take off contaminated clothing and wash it before reuse.
IF exposed: Call a POISON CENTER or doctor/physician.
Get medical advice/attention if you feel unwell.
Storage:
Store locked up.
Disposal:
Dispose of contents/container in accordance with applicable local/regional/national/international regulations.
2.3. Hazards not otherwise classified
None.
SECTION 3: Composition/information on ingredients
Ingredient C.A.S. No. % by Wt
Urethane Polymer Based on MDI Trade Secret* 15 - 40 Trade Secret *
Page 3
__________________________________________________________________________________________
Page 3 of 12
Phenol alkylsulfonate Trade Secret* 15 - 40 Trade Secret *
Poly (Vinyl Chloride) 9002-86-2 10 - 30 Trade Secret *
Calcium Oxide 1305-78-8 1 - 5 Trade Secret *
Xylene 1330-20-7 1 - 5 Trade Secret *
Titanium Dioxide 13463-67-7 1 - 5 Trade Secret *
Ethylbenzene 100-41-4 < 1 Trade Secret *
*The specific chemical identity and/or exact percentage (concentration) of this composition has been withheld as a trade
secret.
SECTION 4: First aid measures
4.1. Description of first aid measures
Inhalation:
Remove person to fresh air. If you feel unwell, get medical attention.
Skin Contact:
Immediately wash with soap and water. Remove contaminated clothing and wash before reuse. If signs/symptoms develop,
get medical attention.
Eye Contact:
Immediately flush with large amounts of water for at least 15 minutes. Remove contact lenses if easy to do. Continue
rinsing. Immediately get medical attention.
If Swallowed:
Rinse mouth. If you feel unwell, get medical attention.
4.2. Most important symptoms and effects, both acute and delayed
See Section 11.1. Information on toxicological effects.
4.3. Indication of any immediate medical attention and special treatment required
Not applicable
SECTION 5: Fire-fighting measures
5.1. Suitable extinguishing media
In case of fire: Use a fire fighting agent suitable for ordinary combustible material such as water or foam to extinguish.
5.2. Special hazards arising from the substance or mixture
None inherent in this product.
Hazardous Decomposition or By-Products
Substance Condition
Carbon monoxide During Combustion
Carbon dioxide During Combustion
Hydrogen Cyanide During Combustion
Irritant Vapors or Gases During Combustion
Oxides of Nitrogen During Combustion
5.3. Special protective actions for fire-fighters
No special protective actions for fire-fighters are anticipated.
Page 4
__________________________________________________________________________________________
Page 4 of 12
SECTION 6: Accidental release measures
6.1. Personal precautions, protective equipment and emergency procedures
Ventilate the area with fresh air. Refer to other sections of this SDS for information regarding physical and health hazards,
respiratory protection, ventilation, and personal protective equipment.
6.2. Environmental precautions
Avoid release to the environment.
6.3. Methods and material for containment and cleaning up
Collect as much of the spilled material as possible. Place in a closed container approved for transportation by appropriate
authorities. Clean up residue. Seal the container. Dispose of collected material as soon as possible.
SECTION 7: Handling and storage
7.1. Precautions for safe handling
Keep out of reach of children. Do not handle until all safety precautions have been read and understood. Do not breathe
dust/fume/gas/mist/vapors/spray. Do not get in eyes, on skin, or on clothing. Do not eat, drink or smoke when using this
product. Wash thoroughly after handling. Use personal protective equipment (gloves, respirators, etc.) as required.
7.2. Conditions for safe storage including any incompatibilities
Keep container tightly closed to prevent contamination with water or air. If contamination is suspected, do not reseal
container. Store away from heat. Store away from amines.
SECTION 8: Exposure controls/personal protection
8.1. Control parameters
Occupational exposure limits
Ingredient C.A.S. No. Agency Limit type Additional Comments
Ethylbenzene 100-41-4 ACGIH TWA:20 ppm
Ethylbenzene 100-41-4 CMRG TWA:25 ppm;STEL:75 ppm
Ethylbenzene 100-41-4 OSHA TWA:435 mg/m3(100 ppm)
Calcium Oxide 1305-78-8 ACGIH TWA:2 mg/m3
Calcium Oxide 1305-78-8 OSHA TWA:5 mg/m3
Xylene 1330-20-7 ACGIH TWA:100 ppm;STEL:150 ppm
Xylene 1330-20-7 CMRG TWA:50 ppm;STEL:75 ppm
Xylene 1330-20-7 OSHA TWA:435 mg/m3(100 ppm)
Titanium Dioxide 13463-67-7 ACGIH TWA:10 mg/m3
Titanium Dioxide 13463-67-7 CMRG TWA(as respirable dust):5
mg/m3
Titanium Dioxide 13463-67-7 OSHA TWA(as total dust):15 mg/m3
Poly (Vinyl Chloride) 9002-86-2 ACGIH TWA(respirable fraction):1
mg/m3
ACGIH : American Conference of Governmental Industrial Hygienists
AIHA : American Industrial Hygiene Association
CMRG : Chemical Manufacturer's Recommended Guidelines
OSHA : United States Department of Labor - Occupational Safety and Health Administration
TWA: Time-Weighted-Average
STEL: Short Term Exposure Limit
CEIL: Ceiling
8.2. Exposure controls
Page 5
__________________________________________________________________________________________
Page 5 of 12
8.2.1. Engineering controls
Use general dilution ventilation and/or local exhaust ventilation to control airborne exposures to below relevant Exposure
Limits and/or control dust/fume/gas/mist/vapors/spray. If ventilation is not adequate, use respiratory protection equipment.
8.2.2. Personal protective equipment (PPE)
Eye/face protection
Select and use eye/face protection to prevent contact based on the results of an exposure assessment. The following eye/face
protection(s) are recommended:
Indirect Vented Goggles
Skin/hand protection
Select and use gloves and/or protective clothing approved to relevant local standards to prevent skin contact based on the
results of an exposure assessment. Selection should be based on use factors such as exposure levels, concentration of the
substance or mixture, frequency and duration, physical challenges such as temperature extremes, and other use conditions.
Consult with your glove and/or protective clothing manufacturer for selection of appropriate compatible gloves/protective
clothing.
Gloves made from the following material(s) are recommended: Nitrile Rubber
Respiratory protection
An exposure assessment may be needed to decide if a respirator is required. If a respirator is needed, use respirators as part of
a full respiratory protection program. Based on the results of the exposure assessment, select from the following respirator
type(s) to reduce inhalation exposure:
Half facepiece or full facepiece air-purifying respirator suitable for organic vapors and particulates
For questions about suitability for a specific application, consult with your respirator manufacturer.
SECTION 9: Physical and chemical properties
9.1. Information on basic physical and chemical properties
General Physical Form:
Solid
Specific Physical Form:
Paste
Odor, Color, Grade:
Gray mild odor
Odor threshold
No Data Available
pH
Not Applicable
Melting point
No Data Available
Boiling Point
137 ºC
Flash Point
No flash point
Evaporation rate
No Data Available
Flammability (solid, gas)
Not Classified
Flammable Limits(LEL)
Not Applicable
Flammable Limits(UEL)
Not Applicable
Vapor Pressure
Not Applicable
Vapor Density
Not Applicable
Density
1.18 g/cm3
Specific Gravity
1.18 [Ref Std: WATER=1]
Solubility in Water
Negligible
Solubility- non-water
Nil
Partition coefficient: n-octanol/ water
No Data Available
Page 6
__________________________________________________________________________________________
Page 6 of 12
Autoignition temperature
> 200 ºC
Decomposition temperature
No Data Available
Viscosity
No Data Available
Hazardous Air Pollutants
2.3 % weight [Test Method: Calculated]
VOC Less H2O & Exempt Solvents
32 g/l [Test Method: calculated SCAQMD rule 443.1]
Solids Content
> 95 % weight
SECTION 10: Stability and reactivity
10.1. Reactivity
This material may be reactive with certain agents under certain conditions - see the remaining headings in this section.
10.2. Chemical stability
Stable.
10.3. Possibility of hazardous reactions
Hazardous polymerization will not occur.
10.4. Conditions to avoid
Heat
10.5. Incompatible materials
Alcohols
Amines
Water
10.6. Hazardous decomposition products
Substance Condition
None known.
Refer to section 5.2 for hazardous decomposition products during combustion.
SECTION 11: Toxicological information
The information below may not be consistent with the material classification in Section 2 if specific ingredient
classifications are mandated by a competent authority. In addition, toxicological data on ingredients may not be
reflected in the material classification and/or the signs and symptoms of exposure, because an ingredient may be
present below the threshold for labeling, an ingredient may not be available for exposure, or the data may not be
relevant to the material as a whole.
11.1. Information on Toxicological effects
Signs and Symptoms of Exposure
Based on test data and/or information on the components, this material may produce the following health effects:
Inhalation:
Respiratory Tract Irritation: Signs/symptoms may include cough, sneezing, nasal discharge, headache, hoarseness, and nose
and throat pain.
May cause target organ effects after inhalation.
Page 7
__________________________________________________________________________________________
Page 7 of 12
Skin Contact:
Skin Irritation: Signs/symptoms may include localized redness, swelling, itching, dryness, cracking, blistering, and pain.
Eye Contact:
Severe Eye Irritation: Signs/symptoms may include significant redness, swelling, pain, tearing, cloudy appearance of the
cornea, and impaired vision.
Ingestion:
Gastrointestinal Irritation: Signs/symptoms may include abdominal pain, stomach upset, nausea, vomiting and diarrhea.
May cause target organ effects after ingestion.
Target Organ Effects:
Single exposure may cause:
Auditory Effects: Signs/symptoms may include hearing impairment, balance dysfunction and ringing in the ears.
Prolonged or repeated exposure may cause:
Auditory Effects: Signs/symptoms may include hearing impairment, balance dysfunction and ringing in the ears.
Neurological Effects: Signs/symptoms may include personality changes, lack of coordination, sensory loss, tingling or
numbness of the extremities, weakness, tremors, and/or changes in blood pressure and heart rate.
Carcinogenicity:
Contains a chemical or chemicals which can cause cancer.
Ingredient C.A.S. No. Class Description Regulation
Ethylbenzene 100-41-4 Grp. 2B: Possible human carc. International Agency for Research on Cancer
Titanium Dioxide 13463-67-7 Grp. 2B: Possible human carc. International Agency for Research on Cancer
Toxicological Data
If a component is disclosed in section 3 but does not appear in a table below, either no data are available for that endpoint or
the data are not sufficient for classification.
Acute Toxicity
Name Route Species Value
Overall product Dermal No data available; calculated ATE > 5,000 mg/kg
Overall product Inhalation-
Vapor(4 hr)
No data available; calculated ATE > 50 mg/l
Overall product Ingestion No data available; calculated ATE > 5,000 mg/kg
Phenol alkylsulfonate Dermal Rat LD50 > 1,000 mg/kg
Phenol alkylsulfonate Ingestion Rat LD50 > 5,000 mg/kg
Urethane Polymer Based on MDI Ingestion Rat LD50 > 5,000 mg/kg
Poly (Vinyl Chloride) Dermal LD50 estimated to be > 5,000 mg/kg
Poly (Vinyl Chloride) Ingestion LD50 estimated to be > 5,000 mg/kg
Titanium Dioxide Dermal Rabbit LD50 > 10,000 mg/kg
Titanium Dioxide Inhalation-
Dust/Mist
(4 hours)
Rat LC50 > 6.82 mg/l
Titanium Dioxide Ingestion Rat LD50 > 10,000 mg/kg
Calcium Oxide Ingestion Rat LD50 500-2000 mg/kg
Xylene Dermal Rabbit LD50 > 4,200 mg/kg
Xylene Inhalation-
Vapor (4
hours)
Rat LC50 29 mg/l
Xylene Ingestion Rat LD50 3,523 mg/kg
Ethylbenzene Dermal Rabbit LD50 15,433 mg/kg
Ethylbenzene Inhalation-
Vapor (4
hours)
Rat LC50 17.4 mg/l
Page 8
__________________________________________________________________________________________
Page 8 of 12
Ethylbenzene Ingestion Rat LD50 4,769 mg/kg
ATE = acute toxicity estimate
Skin Corrosion/Irritation
Name Species Value
Poly (Vinyl Chloride) No significant irritation
Titanium Dioxide Rabbit No significant irritation
Calcium Oxide official
classifica
tion
Corrosive
Xylene Rabbit Mild irritant
Ethylbenzene Rabbit Mild irritant
Serious Eye Damage/Irritation
Name Species Value
Titanium Dioxide Rabbit No significant irritation
Calcium Oxide Rabbit Corrosive
Xylene Rabbit Mild irritant
Ethylbenzene Rabbit Moderate irritant
Skin Sensitization
Name Species Value
Titanium Dioxide Human
and
animal
Not sensitizing
Ethylbenzene Human Not sensitizing
Respiratory Sensitization
Name Species Value
Germ Cell Mutagenicity
Name Route Value
Poly (Vinyl Chloride) In Vitro Not mutagenic
Titanium Dioxide In Vitro Not mutagenic
Titanium Dioxide In vivo Not mutagenic
Calcium Oxide In Vitro Not mutagenic
Xylene In Vitro Not mutagenic
Xylene In vivo Not mutagenic
Ethylbenzene In vivo Not mutagenic
Ethylbenzene In Vitro Some positive data exist, but the data are not
sufficient for classification
Carcinogenicity
Name Route Species Value
Poly (Vinyl Chloride) Not
Specified
Rat Some positive data exist, but the data are not
sufficient for classification
Titanium Dioxide Ingestion Multiple
animal
species
Not carcinogenic
Titanium Dioxide Inhalation Rat Carcinogenic
Xylene Dermal Rat Not carcinogenic
Xylene Ingestion Multiple
animal
species
Not carcinogenic
Xylene Inhalation Human Some positive data exist, but the data are not
sufficient for classification
Ethylbenzene Inhalation Multiple
animal
species
Carcinogenic
Reproductive Toxicity
Page 9
__________________________________________________________________________________________
Page 9 of 12
Reproductive and/or Developmental Effects
Name Route Value Species Test Result Exposure
Duration
Poly (Vinyl Chloride) Not
Specified
Not toxic to development Mouse NOAEL Not
available
during
gestation
Xylene Ingestion Not toxic to female reproduction Mouse NOAEL
1,000
mg/kg/day
103 weeks
Xylene Ingestion Not toxic to male reproduction Mouse NOAEL
1,000
mg/kg/day
103 weeks
Xylene Inhalation Some positive female reproductive data
exist, but the data are not sufficient for
classification
Human NOAEL Not
available
occupational
exposure
Xylene Ingestion Some positive developmental data exist,
but the data are not sufficient for
classification
Mouse NOAEL Not
available
during
organogenesi
s
Xylene Inhalation Some positive developmental data exist,
but the data are not sufficient for
classification
Multiple
animal
species
NOAEL Not
available
during
gestation
Ethylbenzene Inhalation Some positive developmental data exist,
but the data are not sufficient for
classification
Rat NOAEL 4.3
mg/l
premating &
during
gestation
Lactation
Name Route Species Value
Xylene Ingestion Mouse Does not cause effects on or via lactation
Target Organ(s)
Specific Target Organ Toxicity - single exposure
Name Route Target Organ(s) Value Species Test Result Exposure
Duration
Calcium Oxide Inhalation respiratory irritation May cause respiratory irritation Not
available
NOAEL Not
available
occupational
exposure
Xylene Inhalation auditory system Causes damage to organs Rat LOAEL 6.3
mg/l
8 hours
Xylene Inhalation central nervous
system depression
May cause drowsiness or
dizziness
Human NOAEL Not
available
Xylene Inhalation respiratory irritation Some positive data exist, but the
data are not sufficient for
classification
Human NOAEL Not
available
Xylene Inhalation eyes Some positive data exist, but the
data are not sufficient for
classification
Rat NOAEL 3.5
mg/l
not available
Xylene Inhalation liver Some positive data exist, but the
data are not sufficient for
classification
Multiple
animal
species
NOAEL Not
available
Xylene Ingestion central nervous
system depression
May cause drowsiness or
dizziness
Multiple
animal
species
NOAEL Not
available
Xylene Ingestion eyes Some positive data exist, but the
data are not sufficient for
classification
Rat NOAEL 250
mg/kg
not applicable
Ethylbenzene Inhalation central nervous
system depression
May cause drowsiness or
dizziness
Human NOAEL Not
available
Ethylbenzene Inhalation respiratory irritation Some positive data exist, but the
data are not sufficient for
classification
Human
and
animal
NOAEL Not
available
Specific Target Organ Toxicity - repeated exposure
Name Route Target Organ(s) Value Species Test Result Exposure
Duration
Poly (Vinyl Chloride) Inhalation respiratory system Some positive data exist, but the Multiple NOAEL .013 22 months
Page 10
__________________________________________________________________________________________
Page 10 of 12
data are not sufficient for
classification
animal
species
mg/l
Titanium Dioxide Inhalation respiratory system Some positive data exist, but the
data are not sufficient for
classification
Rat LOAEL
0.010 mg/l
2 years
Titanium Dioxide Inhalation pulmonary fibrosis All data are negative Human NOAEL Not
available
occupational
exposure
Xylene Inhalation nervous system Causes damage to organs
through prolonged or repeated
exposure
Rat LOAEL 0.4
mg/l
4 weeks
Xylene Inhalation auditory system May cause damage to organs
though prolonged or repeated
exposure
Rat LOAEL 7.8
mg/l
5 days
Xylene Inhalation liver Some positive data exist, but the
data are not sufficient for
classification
Multiple
animal
species
NOAEL Not
available
Xylene Inhalation heart | endocrine
system |
hematopoietic
system | muscles |
kidney and/or
bladder | respiratory
system
All data are negative Multiple
animal
species
NOAEL 3.5
mg/l
13 weeks
Xylene Ingestion auditory system Some positive data exist, but the
data are not sufficient for
classification
Rat NOAEL 900
mg/kg/day
2 weeks
Xylene Ingestion kidney and/or
bladder
Some positive data exist, but the
data are not sufficient for
classification
Rat NOAEL
1,500
mg/kg/day
90 days
Xylene Ingestion liver Some positive data exist, but the
data are not sufficient for
classification
Multiple
animal
species
NOAEL Not
available
Xylene Ingestion heart | skin |
endocrine system |
bone, teeth, nails,
and/or hair |
hematopoietic
system | immune
system | nervous
system | respiratory
system
All data are negative Mouse NOAEL
1,000
mg/kg/day
103 weeks
Ethylbenzene Inhalation kidney and/or
bladder
Some positive data exist, but the
data are not sufficient for
classification
Rat NOAEL 1.1
mg/l
2 years
Ethylbenzene Inhalation liver Some positive data exist, but the
data are not sufficient for
classification
Mouse NOAEL 1.1
mg/l
103 weeks
Ethylbenzene Inhalation hematopoietic
system
Some positive data exist, but the
data are not sufficient for
classification
Rat NOAEL 3.4
mg/l
28 days
Ethylbenzene Inhalation auditory system Some positive data exist, but the
data are not sufficient for
classification
Rat NOAEL 2.4
mg/l
5 days
Ethylbenzene Inhalation endocrine system Some positive data exist, but the
data are not sufficient for
classification
Mouse NOAEL 3.3
mg/l
103 weeks
Ethylbenzene Inhalation bone, teeth, nails,
and/or hair |
muscles
All data are negative Multiple
animal
species
NOAEL 4.2
mg/l
90 days
Ethylbenzene Inhalation heart | immune
system | respiratory
system
All data are negative Multiple
animal
species
NOAEL 3.3
mg/l
2 years
Ethylbenzene Ingestion liver | kidney and/or
bladder
Some positive data exist, but the
data are not sufficient for
classification
Rat NOAEL 680
mg/kg/day
6 months
Aspiration Hazard
Name Value
Page 11
__________________________________________________________________________________________
Page 11 of 12
Xylene Aspiration hazard
Ethylbenzene Aspiration hazard
Please contact the address or phone number listed on the first page of the SDS for additional toxicological information
on this material and/or its components.
SECTION 12: Ecological information
Ecotoxicological information
Please contact the address or phone number listed on the first page of the SDS for additional ecotoxicological information on this material
and/or its components.
Chemical fate information
Please contact the address or phone number listed on the first page of the SDS for additional chemical fate information on this material
and/or its components.
SECTION 13: Disposal considerations
13.1. Disposal methods
Dispose of contents/ container in accordance with the local/regional/national/international regulations.
Dispose of completely cured (or polymerized) material in a permitted industrial waste facility. As a disposal alternative,
incinerate uncured product in a permitted waste incineration facility. Proper destruction may require the use of additional fuel
during incineration processes. Empty drums/barrels/containers used for transporting and handling hazardous chemicals
(chemical substances/mixtures/preparations classified as Hazardous as per applicable regulations) shall be considered, stored,
treated & disposed of as hazardous wastes unless otherwise defined by applicable waste regulations. Consult with the
respective regulating authorities to determine the available treatment and disposal facilities.
EPA Hazardous Waste Number (RCRA): Not regulated
SECTION 14: Transport Information
Please contact the emergency numbers listed on the first page of the MSDS for Transportation Information for this material.
SECTION 15: Regulatory information
15.1. US Federal Regulations
Contact manufacturer for more information
311/312 Hazard Categories:
Fire Hazard - No Pressure Hazard - No Reactivity Hazard - No Immediate Hazard - Yes Delayed Hazard - Yes
Section 313 Toxic Chemicals subject to the reporting requirements of that section and 40 CFR part 372 (EPCRA):
Ingredient C.A.S. No % by Wt
Xylene (Benzene, dimethyl-) 1330-20-7 1 - 5
Xylene (Benzene, 1,3-dimethyl-) 1330-20-7 1 - 5
Xylene 1330-20-7 1 - 5
Xylene (Benzene, 1,2-dimethyl-) 1330-20-7 1 - 5
Xylene (Benzene, 1,4-dimethyl-) 1330-20-7 1 - 5
Ethylbenzene 100-41-4 < 1
Page 12
__________________________________________________________________________________________
Page 12 of 12
15.2. State Regulations
Contact manufacturer for more information
California Proposition 65
Ingredient C.A.S. No. Classification
Ethylbenzene 100-41-4 Carcinogen
Titanium Dioxide 13463-67-7 Carcinogen
WARNING: This product contains a chemical known to the State of California to cause cancer.
15.3. Chemical Inventories
The components of this product are in compliance with the chemical notification requirements of TSCA.
Contact manufacturer for more information
15.4. International Regulations
Contact manufacturer for more information
This SDS has been prepared to meet the U.S. OSHA Hazard Communication Standard, 29 CFR 1910.1200.
SECTION 16: Other information
NFPA Hazard Classification
Health: 2 Flammability: 1 Instability: 0 Special Hazards: None
National Fire Protection Association (NFPA) hazard ratings are designed for use by emergency response personnel to address
the hazards that are presented by short-term, acute exposure to a material under conditions of fire, spill, or similar
emergencies. Hazard ratings are primarily based on the inherent physical and toxic properties of the material but also include
the toxic properties of combustion or decomposition products that are known to be generated in significant quantities.
Version Number:
3.01
Issue Date:
06/19/14
Supercedes Date:
05/09/14
DISCLAIMER: The information in this Safety Data Sheet (SDS) is believed to be correct as of the date issued. Sakrete of
North America MAKES NO WARRANTIES, EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, ANY
IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR COURSE OF
PERFORMANCE OR USAGE OF TRADE. User is responsible for determining whether the Sakrete of North America
product is fit for a particular purpose and suitable for user's method of use or application. Given the variety of factors that
can affect the use and application of a Sakrete of North America product, some of which are uniquely within the user's
knowledge and control, it is essential that the user evaluate the Sakrete of North America product to determine whether it is
fit for a particular purpose and suitable for user's method of use or application.
Sakrete of North America provides information in electronic form as a service to its customers. Due to the remote possibility
that electronic transfer may have resulted in errors, omissions or alterations in this information, Sakrete of North America
makes no representations as to its completeness or accuracy. In addition, information obtained from a database may not be as
current as the information in the SDS available directly from Sakrete of North America.
Sakrete of North America USA SDSs are available at www.sakrete.com
Loading...